Published in Biochim Biophys Acta on April 12, 1979
Mass spectrometry-based strategies for characterization of histones and their post-translational modifications. Expert Rev Proteomics (2007) 0.98
Enrichment and characterization of histones by two-dimensional hydroxyapatite/reversed-phase liquid chromatography-mass spectrometry. Anal Biochem (2009) 0.78
Participation of c-myc protein in DNA synthesis of human cells. Science (1986) 2.22
Selective inhibition of the cell cycle of cultured human diploid fibroblasts by aminonucleoside of puromycin. J Cell Physiol (1973) 1.50
Thymidine as a synchronizing agent. I. Nucleic acid and protein formation in synchronous HeLa cultures treated with excess thymidine. J Cell Physiol (1969) 1.45
Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res (1996) 1.45
Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells. J Cell Biochem (2001) 1.34
Correlation between cell enlargement and nucleic acid and protein content of HeLa cells in unbalanced growth produced by inhibitors of DNA synthesis. J Cell Physiol (1967) 1.21
An autoradiographic screening test for mycoplasmal contamination of mammalian cell cultures. In Vitro (1973) 1.16
Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents. J Natl Cancer Inst (2001) 1.15
Xeroderma pigmentosum. Dermatol Clin (1995) 1.08
Thymidine as a synchronizing agent. II. Partial recovery of HeLa cells from unbalanced growth. J Cell Physiol (1969) 1.07
Inhibition of p38 MAP kinase activity up-regulates multiple MAP kinase pathways and potentiates 1,25-dihydroxyvitamin D(3)-induced differentiation of human leukemia HL60 cells. Exp Cell Res (2000) 1.05
Thymidine as synchronizing agent. 3. Persistence of cell cycle patterns of phosphatase activities and elevation of nuclease activity during inhibition of DNA synthesis. J Cell Physiol (1970) 1.04
A system for monocytic differentiation of leukemic cells HL 60 by a short exposure to 1,25-dihydroxycholecalciferol. Proc Soc Exp Biol Med (1985) 1.03
Fanconi anemia, complementation group A, cells are defective in ability to produce incisions at sites of psoralen interstrand cross-links. Carcinogenesis (2000) 1.03
Human alpha spectrin II and the Fanconi anemia proteins FANCA and FANCC interact to form a nuclear complex. J Biol Chem (1999) 1.03
Human alpha spectrin II and the FANCA, FANCC, and FANCG proteins bind to DNA containing psoralen interstrand cross-links. Biochemistry (2001) 1.00
Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells. J Cell Biochem (2001) 0.99
Human endonucleolytic incision of DNA 3' and 5' to a site-directed psoralen monoadduct and interstrand cross-link. J Biol Chem (1995) 0.98
Cell cycle sensitivity of HL-60 cells to the differentiation-inducing effects of 1-alpha,25-dihydroxyvitamin D3. Cancer Res (1985) 0.97
Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein. J Cell Biochem (1997) 0.96
Teniposide induces nuclear but not mitochondrial DNA degradation. Cancer Res (1992) 0.96
Expression of the neuronal cyclin-dependent kinase 5 activator p35Nck5a in human monocytic cells is associated with differentiation. Blood (2001) 0.95
Differentiation-related mechanisms which suppress DNA replication. Exp Cell Res (1999) 0.93
Co-recessive inheritance: a model for DNA repair, genetic disease and carcinogenesis. Mutat Res (1985) 0.93
Phosphorylation of raf-1 by kinase suppressor of ras is inhibited by "MEK-specific" inhibitors PD 098059 and U0126 in differentiating HL60 cells. Exp Cell Res (2001) 0.93
Synergistic induction of HL60 cell differentiation by ketoconazole and 1-desoxy analogues of vitamin D3. J Natl Cancer Inst (1997) 0.93
Translational study of vitamin D differentiation therapy of myeloid leukemia: effects of the combination with a p38 MAPK inhibitor and an antioxidant. Leukemia (2005) 0.92
Antiapoptotic action of 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c. Exp Cell Res (1997) 0.91
Induction of kinase suppressor of RAS-1(KSR-1) gene by 1, alpha25-dihydroxyvitamin D3 in human leukemia HL60 cells through a vitamin D response element in the 5'-flanking region. Oncogene (2006) 0.91
Loss of deoxcytidine kinase expression and tetraploidization of HL60 cells following long-term culture in 1,25-dihydroxyvitamin D3. Exp Cell Res (1996) 0.90
Relationship between RNA synthesis, cell division, and morphology of mammalian cells. I. Puromycin aminonucleoside as an inhibitor of RNA synthesis and division in HeLa cells. J Cell Biol (1966) 0.89
Deficient DNA binding of an apurinic/apyrimidinic DNA endonuclease activity from xeroderma pigmentosum cells. Cell Biol Int Rep (1988) 0.88
Cytologic appearance of the nucleolus of normal and neoplastic cells in relation to the synthesis of RNA. Acta Cytol (1972) 0.87
Highly active analogs of 1alpha,25-dihydroxyvitamin D(3) that resist metabolism through C-24 oxidation and C-3 epimerization pathways. Steroids (2001) 0.86
A correlated morphological and functional study of the effects of actinomycin D on HeLa cells. I. Effects on the nucleolar and cytoplasmic ribonucleoproteins. Exp Cell Res (1967) 0.86
Mitomycin C induced increases in the activities of the deoxyribonucleases of HeLa cells. Biochem Biophys Res Commun (1966) 0.85
Differences between diploid and heteroploid cultured mammalian cells in their response to puromycin aminonucleoside. Cancer Res (1968) 0.85
Constitutive DNA binding of the low mobility forms of the AP-1 and SP-1 transcription factors in HL60 cells resistant to 1-beta-D-arabinofuranosylcytosine. Cancer Res (1994) 0.84
1,25-Dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Exp Cell Res (1993) 0.83
Autoradiographic studies of the effects of inhibitors of protein synthesis on RNA synthesis in HeLa cells. Exp Cell Res (1968) 0.83
Selective inhibition of preribosomal RNA synthesis by puromycin aminonucleoside in transformed human fibroblasts: studies of the nature of the inhibition in isolated nuclei and nucleoli. J Cell Physiol (1979) 0.83
Instability of puromycin. Nature (1966) 0.83
Coordinate expression of c-myc, c-myb, and histone H4 genes in reversibly differentiating HL 60 cells. J Cell Physiol (1987) 0.82
Ectopic expression of truncated Sp1 transcription factor prolongs the S phase and reduces the growth rate. Anticancer Res (2000) 0.82
p53/56(lyn) antisense shifts the 1,25-dihydroxyvitamin D3-induced G1/S block in HL60 cells to S phase. J Cell Physiol (2000) 0.82
Lowering of p27Kip1 levels by its antisense or by development of resistance to 1,25-dihydroxyvitamin D3 reverses the G1 block but not differentiation of HL60 cells. Leukemia (1998) 0.82
A processive versus a distributive mechanism of action correlates with differences in ability of normal and xeroderma pigmentosum group A endonucleases to incise damaged nucleosomal DNA. Carcinogenesis (1997) 0.81
Changes in proto-oncogene expression associated with reversal of macrophage-like differentiation of HL 60 cells. J Natl Cancer Inst (1987) 0.81
A damage-recognition protein which binds to DNA containing interstrand cross-links is absent or defective in Fanconi anemia, complementation group A, cells. Nucleic Acids Res (1993) 0.81
Resistance of mitochondrial DNA to degradation characterizes the apoptotic but not the necrotic mode of human leukemia cell death. J Cell Biochem (1993) 0.81
Chromatin-associated DNA endonucleases from xeroderma pigmentosum cells are defective in interaction with damaged nucleosomal DNA. Mutat Res (1990) 0.81
Long-term exposure of HL60 cells to 1,25-dihydroxyvitamin D3 reduces their tumorigenicity: a model for cancer chemoprevention. Proc Soc Exp Biol Med (1997) 0.81
Potentiation by 1-alpha,25-dihydroxyvitamin D3 of cytotoxicity to HL-60 cells produced by cytarabine and hydroxyurea. J Natl Cancer Inst (1986) 0.80
A deficiency in a 230 kDa DNA repair protein in fanconi anemia complementation group A cells is corrected by the FANCA cDNA. Carcinogenesis (1999) 0.80
A dual block to cell cycle progression in HL60 cells exposed to analogues of vitamin D3. Cell Prolif (1994) 0.80
Definition of the cell cycle segment with special sensitivity to vinblastine. Proc Soc Exp Biol Med (1978) 0.79
Specific association of increased cyclin-dependent kinase 5 expression with monocytic lineage of differentiation of human leukemia HL60 cells. J Leukoc Biol (2000) 0.79
Nuclear deoxyribonuclease activities in human lymphoblastoid and mouse melanoma cells. A comparative study. Biochim Biophys Acta (1982) 0.79
Methods for assessment of DNase activity. Methods Cell Biol (1978) 0.79
Increased expression of oncogene c-Ha-ras during granulocytic differentiation of HL60 cells. Lab Invest (1987) 0.79
Inhibition of DNA synthesis by an inducer of differentiation of leukemic cells, 1 alpha, 25 dihydroxy vitamin D3, precedes down regulation of the c-myc gene. J Cell Physiol (1986) 0.79
Truncation of Sp1 transcription factor by myeloblastin in undifferentiated HL60 cells. J Cell Physiol (1998) 0.79
Cyclin-dependent kinase 6 is the principal target of p27/Kip1 regulation of the G1-phase traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells. Cancer Res (1997) 0.78
Enhancement of the affinity of nucleoli and chromosomes for zinc by treatment with chromic acid. Stain Technol (1967) 0.78
Visualization of nucleolar substructure in cultured human fibroblasts by magnesium-activated adenosine triphosphatase reaction. J Histochem Cytochem (1981) 0.78
Changes in the expression of oncogenes encoding nuclear phosphoproteins but not c-Ha-ras have a relationship to monocytic differentiation of HL 60 cells. J Cell Biol (1986) 0.78
Use of antimetabolites in the study of normal and abnormal cell structure and function. Fed Proc (1966) 0.78
Nuclear, nucleolinar and cytoplasmic acidphosphatases in cultured mammalian cells. Exp Cell Res (1969) 0.78
Up-regulation of Ca2+ influx mediated by store-operated channels in HL60 cells induced to differentiate by 1 alpha,25-dihydroxyvitamin D3. J Cell Physiol (1997) 0.78
Xeroderma pigmentosum endonuclease complexes show reduced activity on and affinity for psoralen cross-linked nucleosomal DNA. Mutat Res (1992) 0.78
Inhibition by 1,25 dihydroxyvitamin D3 of chemically induced erythroid differentiation of K562 leukemia cells. Blood (1991) 0.78
Cyclin-dependent kinase 5 activity enhances monocytic phenotype and cell cycle traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells. Exp Cell Res (1999) 0.78
Resolution of multiple AP-1 complexes in HL-60 cells induced to differentiate by 1,25-dihydroxyvitamin D3. J Cell Physiol (1993) 0.77
Ozone depletion: the biologic consequences. J Am Acad Dermatol (1992) 0.77
Multiple deoxyribonuclease activities in nuclei of HeLa cells. Biochem Biophys Res Commun (1973) 0.77
Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase. Oncogene (1998) 0.77
Elevation of deoxyribonuclease activities in HeLa cells treated with selective inhibitors of DNA synthesis. Biochem Biophys Res Commun (1966) 0.77
Absence of aminonucleoside-sensitive steps in the cell cycle of SV40-transformed human fibroblasts. Cancer Res (1973) 0.77
DNA endonuclease activities associated with melanoma cell chromatin. Biochem Biophys Res Commun (1979) 0.77
Differentiation-related regulation of 1,25-dihydroxyvitamin D3 receptor mRNA in human leukaemia cells HL-60. Cell Prolif (1991) 0.77
Enhanced messenger RNA stability and differentiation of HL 60 cells treated with 1,25-dihydroxyvitamin D3 and cordycepin. J Cell Physiol (1989) 0.77
Activation of DNA primer for DNA polymerase as an ultrasensitive assay for a subgroup of enzymes with deoxyribonuclease activity. Anal Biochem (1974) 0.77
Nuclear deoxyribonuclease activities in normal and xeroderma pigmentosum lymphoblastoid cells. Biochem Biophys Res Commun (1982) 0.77
Butyrate-induced G2/M block in Caco-2 colon cancer cells is associated with decreased p34cdc2 activity. Proc Soc Exp Biol Med (1999) 0.77
Chromatin-associated DNA endonuclease activities in HeLa cells. Biochem Biophys Res Commun (1974) 0.76
Vitamin D analog 25-(OH)-16,23E-Diene-26,27-hexafluoro-vitamin D3 induces differentiation of HL60 cells with minimal effects on cellular calcium homeostasis. J Cell Biochem (1996) 0.76
Congenital melanocytosis with myelomeningocele and hydrocephalus. Cutis (1986) 0.76
Cellular and molecular mechanisms in wound healing: selected concepts. Clin Dermatol (1986) 0.76
Changes in E2F binding after phenylbutyrate-induced differentiation of Caco-2 colon cancer cells. Clin Cancer Res (2000) 0.76
Inhibition by puromycin of incorporation of tritiated uridine into nucleolar and cytoplasmic ribonucleic acids. Nature (1966) 0.76
Co-recessive inheritance: a model for DNA repair and other surveillance genes in higher eukaryotes. Mutat Res (1992) 0.76
Electroporation of normal human DNA endonucleases into xeroderma pigmentosum cells corrects their DNA repair defect. Carcinogenesis (1990) 0.76
Expression of monocyte-specific oncogenes c-fos and c-fms in HL60 cells treated with vitamin D3 analogs correlates with inhibition of DNA synthesis and reduced calmodulin concentration. Lab Invest (1986) 0.76
Resistance to 1,25-dihydroxyvitamin D3 of a deoxycytidine kinase-deficient variant of human leukemia HL60 cells. Exp Cell Res (1992) 0.76
Metabolic differences between normal and neoplastic cells: effects of aminonucleoside on cytoplasmic messenger RNA. Science (1974) 0.76
1,25-dihydroxyvitamin D(3)-induced retardation of the G(2)/M traverse is associated with decreased levels of p34(cdc2) in HL60 cells. J Cell Biochem (1999) 0.75
Photoaffinity labeling of human c-myc protein with deoxythymidine triphosphate. Lab Invest (1990) 0.75